30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Year in Review

2011 To Date (July 2011): Merger & Acquisition Activity in Orthopaedics and Spine

2Q11

GENZYME
acquired by SANOFI AVENTIS for ~$20.1BB in cash
* sanofi intends to restart expansion of Synvisc-One into treatment of hip as well as knee osteoarthritis
* Genzyme will serve as sanofi’s global center for excellence in rare diseases